Advisors Asset Management, Inc.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1297376 Monument, CO

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$843,069

+$284,976 QoQ

Shares Held

24,884

+34.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#349

of 671 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Advisors Asset Management, Inc. holds $29,351,232 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	885,796	$14,066,440
2	UTHR	UNITED THERAPEUTICS Corp	12,119	$6,566,437
3	ZTS	Zoetis Inc.	51,264	$3,683,831
4	NBIX	Neurocrine Biosciences Inc	17,488	$2,947,427
5	TEVA	Teva Pharmaceutical Industries Ltd This page	24,884	$843,069
6	TAK	Takeda Pharmaceutical Co Ltd	24,309	$389,673
7	ALKS	Alkermes plc.	7,425	$389,070
8	RDY	Dr Reddys Laboratories Ltd	23,253	$336,935

All Filings in TEVA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$843,069	24,884	+34.3%	Shares	Sole	2026-08-14
2026-03-31	$558,093	18,529	+169.7%	Shares	Sole	2026-05-15
2025-12-31	$214,443	6,871	+80.9%	Shares	Sole	2026-08-21
2025-09-30	$76,719	3,798	+55.9%	Shares	Sole	2025-11-06
2025-06-30	$40,827	2,436	+90.2%	Shares	Sole	2025-08-12
2020-12-31	$12,361	1,281	-79.7%	Shares	Sole	2021-02-12
2020-09-30	$56,907	6,316	-11.1%	Shares	Sole	2020-11-16
2020-06-30	$87,604	7,105	-6.9%	Shares	Sole	2020-08-12
2020-03-31	$68,535	7,632	—	Shares	Sole	2026-08-21
No filing history on record for this holder in this stock.